Published by Josh White on 23rd November 2020
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Monday that the first patient had now been enrolled and dosed in the 'STAR' trial of its 'SFX-01' treatment for acute respiratory infections.
URL: http://www.digitallook.com/dl/news/story/31468461/...